nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2C8—Vismodegib—skin cancer	0.146	0.199	CbGbCtD
Montelukast—CYP2A6—Fluorouracil—skin cancer	0.105	0.143	CbGbCtD
Montelukast—CYP2C9—Vismodegib—skin cancer	0.102	0.139	CbGbCtD
Montelukast—CYP3A4—Temozolomide—skin cancer	0.0854	0.116	CbGbCtD
Montelukast—CYP3A4—Imiquimod—skin cancer	0.0854	0.116	CbGbCtD
Montelukast—CYP3A4—Vismodegib—skin cancer	0.0592	0.0807	CbGbCtD
Montelukast—CYP2C8—Fluorouracil—skin cancer	0.0518	0.0706	CbGbCtD
Montelukast—CYP3A4—Vemurafenib—skin cancer	0.0468	0.0638	CbGbCtD
Montelukast—CYP2C9—Fluorouracil—skin cancer	0.0362	0.0493	CbGbCtD
Montelukast—CYP3A4—Docetaxel—skin cancer	0.0161	0.0219	CbGbCtD
Montelukast—Hepatocellular injury—Docetaxel—skin cancer	0.000838	0.00324	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.000823	0.00319	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000823	0.00319	CcSEcCtD
Montelukast—Palpitations—Imiquimod—skin cancer	0.000812	0.00314	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Temozolomide—skin cancer	0.000806	0.00312	CcSEcCtD
Montelukast—Irritability—Fluorouracil—skin cancer	0.000804	0.00311	CcSEcCtD
Montelukast—Cough—Imiquimod—skin cancer	0.000802	0.0031	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000801	0.0031	CcSEcCtD
Montelukast—Convulsion—Imiquimod—skin cancer	0.000796	0.00308	CcSEcCtD
Montelukast—Neuropathy—Docetaxel—skin cancer	0.000786	0.00304	CcSEcCtD
Montelukast—Pneumonia—Dactinomycin—skin cancer	0.000783	0.00303	CcSEcCtD
Montelukast—Arthralgia—Imiquimod—skin cancer	0.000782	0.00303	CcSEcCtD
Montelukast—Myalgia—Imiquimod—skin cancer	0.000782	0.00303	CcSEcCtD
Montelukast—Anxiety—Imiquimod—skin cancer	0.000779	0.00302	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000777	0.00301	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000772	0.00299	CcSEcCtD
Montelukast—Bronchitis—Temozolomide—skin cancer	0.00076	0.00294	CcSEcCtD
Montelukast—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000759	0.00294	CcSEcCtD
Montelukast—Fatigue—Vemurafenib—skin cancer	0.000758	0.00293	CcSEcCtD
Montelukast—Nasopharyngitis—Fluorouracil—skin cancer	0.000753	0.00292	CcSEcCtD
Montelukast—Oedema—Imiquimod—skin cancer	0.00075	0.0029	CcSEcCtD
Montelukast—Hypoaesthesia—Bleomycin—skin cancer	0.000746	0.00289	CcSEcCtD
Montelukast—Infection—Imiquimod—skin cancer	0.000745	0.00288	CcSEcCtD
Montelukast—Nervous system disorder—Imiquimod—skin cancer	0.000735	0.00285	CcSEcCtD
Montelukast—Upper respiratory tract infection—Temozolomide—skin cancer	0.000734	0.00284	CcSEcCtD
Montelukast—Skin disorder—Imiquimod—skin cancer	0.000728	0.00282	CcSEcCtD
Montelukast—Eosinophilia—Fluorouracil—skin cancer	0.000721	0.00279	CcSEcCtD
Montelukast—Pneumonia—Temozolomide—skin cancer	0.000709	0.00274	CcSEcCtD
Montelukast—Infestation—Temozolomide—skin cancer	0.000704	0.00273	CcSEcCtD
Montelukast—Infestation NOS—Temozolomide—skin cancer	0.000704	0.00273	CcSEcCtD
Montelukast—CYSLTR1—mammalian vulva—skin cancer	0.000704	0.0884	CbGeAlD
Montelukast—Hepatitis—Dactinomycin—skin cancer	0.000699	0.00271	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000698	0.0027	CcSEcCtD
Montelukast—Body temperature increased—Vemurafenib—skin cancer	0.000695	0.00269	CcSEcCtD
Montelukast—Pharyngitis—Dactinomycin—skin cancer	0.000694	0.00269	CcSEcCtD
Montelukast—Neuropathy peripheral—Temozolomide—skin cancer	0.000691	0.00267	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000683	0.00264	CcSEcCtD
Montelukast—Insomnia—Imiquimod—skin cancer	0.000678	0.00263	CcSEcCtD
Montelukast—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000677	0.00262	CcSEcCtD
Montelukast—Paraesthesia—Imiquimod—skin cancer	0.000673	0.00261	CcSEcCtD
Montelukast—Somnolence—Imiquimod—skin cancer	0.000667	0.00258	CcSEcCtD
Montelukast—Hepatobiliary disease—Temozolomide—skin cancer	0.000666	0.00258	CcSEcCtD
Montelukast—Erythema multiforme—Dactinomycin—skin cancer	0.000661	0.00256	CcSEcCtD
Montelukast—Sinusitis—Temozolomide—skin cancer	0.000661	0.00256	CcSEcCtD
Montelukast—Dyspepsia—Imiquimod—skin cancer	0.00066	0.00256	CcSEcCtD
Montelukast—Pneumonia—Fluorouracil—skin cancer	0.000653	0.00253	CcSEcCtD
Montelukast—Infestation NOS—Fluorouracil—skin cancer	0.000649	0.00251	CcSEcCtD
Montelukast—Infestation—Fluorouracil—skin cancer	0.000649	0.00251	CcSEcCtD
Montelukast—Hypersensitivity—Vemurafenib—skin cancer	0.000648	0.00251	CcSEcCtD
Montelukast—Gastrointestinal disorder—Imiquimod—skin cancer	0.000647	0.00251	CcSEcCtD
Montelukast—Fatigue—Imiquimod—skin cancer	0.000646	0.0025	CcSEcCtD
Montelukast—Pain—Imiquimod—skin cancer	0.000641	0.00248	CcSEcCtD
Montelukast—Neuropathy peripheral—Fluorouracil—skin cancer	0.000636	0.00246	CcSEcCtD
Montelukast—Hepatitis—Temozolomide—skin cancer	0.000632	0.00245	CcSEcCtD
Montelukast—Conjunctivitis—Fluorouracil—skin cancer	0.000631	0.00244	CcSEcCtD
Montelukast—Asthenia—Vemurafenib—skin cancer	0.000631	0.00244	CcSEcCtD
Montelukast—Hallucination—Temozolomide—skin cancer	0.000629	0.00244	CcSEcCtD
Montelukast—Hypoaesthesia—Temozolomide—skin cancer	0.000629	0.00244	CcSEcCtD
Montelukast—Pharyngitis—Temozolomide—skin cancer	0.000628	0.00243	CcSEcCtD
Montelukast—CYSLTR1—lymphoid tissue—skin cancer	0.000625	0.0785	CbGeAlD
Montelukast—Urinary tract disorder—Temozolomide—skin cancer	0.000625	0.00242	CcSEcCtD
Montelukast—Pruritus—Vemurafenib—skin cancer	0.000622	0.00241	CcSEcCtD
Montelukast—Connective tissue disorder—Temozolomide—skin cancer	0.000621	0.00241	CcSEcCtD
Montelukast—Urethral disorder—Temozolomide—skin cancer	0.00062	0.0024	CcSEcCtD
Montelukast—Gastrointestinal pain—Imiquimod—skin cancer	0.000613	0.00237	CcSEcCtD
Montelukast—Epistaxis—Fluorouracil—skin cancer	0.000612	0.00237	CcSEcCtD
Montelukast—Sinusitis—Fluorouracil—skin cancer	0.000609	0.00236	CcSEcCtD
Montelukast—CYSLTR1—female reproductive system—skin cancer	0.000603	0.0757	CbGeAlD
Montelukast—Diarrhoea—Vemurafenib—skin cancer	0.000602	0.00233	CcSEcCtD
Montelukast—Erythema multiforme—Temozolomide—skin cancer	0.000598	0.00232	CcSEcCtD
Montelukast—Urticaria—Imiquimod—skin cancer	0.000596	0.00231	CcSEcCtD
Montelukast—Abdominal pain—Imiquimod—skin cancer	0.000593	0.00229	CcSEcCtD
Montelukast—Body temperature increased—Imiquimod—skin cancer	0.000593	0.00229	CcSEcCtD
Montelukast—Cardiac disorder—Temozolomide—skin cancer	0.000587	0.00227	CcSEcCtD
Montelukast—Rhinitis—Fluorouracil—skin cancer	0.000584	0.00226	CcSEcCtD
Montelukast—Dizziness—Vemurafenib—skin cancer	0.000581	0.00225	CcSEcCtD
Montelukast—Hypoaesthesia—Fluorouracil—skin cancer	0.00058	0.00224	CcSEcCtD
Montelukast—Pharyngitis—Fluorouracil—skin cancer	0.000578	0.00224	CcSEcCtD
Montelukast—Immune system disorder—Temozolomide—skin cancer	0.000571	0.00221	CcSEcCtD
Montelukast—Mediastinal disorder—Temozolomide—skin cancer	0.00057	0.00221	CcSEcCtD
Montelukast—Cough—Bleomycin—skin cancer	0.000569	0.00221	CcSEcCtD
Montelukast—Vomiting—Vemurafenib—skin cancer	0.000559	0.00216	CcSEcCtD
Montelukast—Myalgia—Bleomycin—skin cancer	0.000556	0.00215	CcSEcCtD
Montelukast—Rash—Vemurafenib—skin cancer	0.000554	0.00215	CcSEcCtD
Montelukast—Mental disorder—Temozolomide—skin cancer	0.000554	0.00215	CcSEcCtD
Montelukast—Dermatitis—Vemurafenib—skin cancer	0.000554	0.00214	CcSEcCtD
Montelukast—Hypersensitivity—Imiquimod—skin cancer	0.000552	0.00214	CcSEcCtD
Montelukast—Headache—Vemurafenib—skin cancer	0.000551	0.00213	CcSEcCtD
Montelukast—Cramp muscle—Docetaxel—skin cancer	0.000547	0.00212	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000547	0.00212	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000547	0.00212	CcSEcCtD
Montelukast—Nasopharyngitis—Docetaxel—skin cancer	0.000544	0.0021	CcSEcCtD
Montelukast—Asthenia—Imiquimod—skin cancer	0.000538	0.00208	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000536	0.00208	CcSEcCtD
Montelukast—Oedema—Bleomycin—skin cancer	0.000533	0.00206	CcSEcCtD
Montelukast—Anaphylactic shock—Bleomycin—skin cancer	0.000533	0.00206	CcSEcCtD
Montelukast—Pruritus—Imiquimod—skin cancer	0.00053	0.00205	CcSEcCtD
Montelukast—Infection—Bleomycin—skin cancer	0.000529	0.00205	CcSEcCtD
Montelukast—Nausea—Vemurafenib—skin cancer	0.000522	0.00202	CcSEcCtD
Montelukast—Thrombocytopenia—Bleomycin—skin cancer	0.000522	0.00202	CcSEcCtD
Montelukast—Myalgia—Dactinomycin—skin cancer	0.000518	0.00201	CcSEcCtD
Montelukast—ALOX5—connective tissue—skin cancer	0.000517	0.065	CbGeAlD
Montelukast—Tremor—Temozolomide—skin cancer	0.000516	0.002	CcSEcCtD
Montelukast—Diarrhoea—Imiquimod—skin cancer	0.000513	0.00199	CcSEcCtD
Montelukast—Agitation—Temozolomide—skin cancer	0.000506	0.00196	CcSEcCtD
Montelukast—CYSLTR1—head—skin cancer	0.000503	0.0632	CbGeAlD
Montelukast—Angioedema—Temozolomide—skin cancer	0.000503	0.00195	CcSEcCtD
Montelukast—Oedema—Dactinomycin—skin cancer	0.000497	0.00192	CcSEcCtD
Montelukast—Dizziness—Imiquimod—skin cancer	0.000496	0.00192	CcSEcCtD
Montelukast—Infection—Dactinomycin—skin cancer	0.000494	0.00191	CcSEcCtD
Montelukast—Palpitations—Temozolomide—skin cancer	0.000486	0.00188	CcSEcCtD
Montelukast—Thrombocytopenia—Dactinomycin—skin cancer	0.000486	0.00188	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000485	0.00188	CcSEcCtD
Montelukast—Cough—Temozolomide—skin cancer	0.00048	0.00186	CcSEcCtD
Montelukast—Paraesthesia—Bleomycin—skin cancer	0.000478	0.00185	CcSEcCtD
Montelukast—Convulsion—Temozolomide—skin cancer	0.000477	0.00185	CcSEcCtD
Montelukast—Vomiting—Imiquimod—skin cancer	0.000477	0.00185	CcSEcCtD
Montelukast—Rash—Imiquimod—skin cancer	0.000473	0.00183	CcSEcCtD
Montelukast—Dermatitis—Imiquimod—skin cancer	0.000472	0.00183	CcSEcCtD
Montelukast—Pneumonia—Docetaxel—skin cancer	0.000471	0.00182	CcSEcCtD
Montelukast—Headache—Imiquimod—skin cancer	0.00047	0.00182	CcSEcCtD
Montelukast—Myalgia—Temozolomide—skin cancer	0.000469	0.00181	CcSEcCtD
Montelukast—Arthralgia—Temozolomide—skin cancer	0.000469	0.00181	CcSEcCtD
Montelukast—Infestation NOS—Docetaxel—skin cancer	0.000468	0.00181	CcSEcCtD
Montelukast—Infestation—Docetaxel—skin cancer	0.000468	0.00181	CcSEcCtD
Montelukast—Anxiety—Temozolomide—skin cancer	0.000467	0.00181	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000465	0.0018	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000464	0.0018	CcSEcCtD
Montelukast—Neuropathy peripheral—Docetaxel—skin cancer	0.000459	0.00178	CcSEcCtD
Montelukast—Jaundice—Docetaxel—skin cancer	0.000457	0.00177	CcSEcCtD
Montelukast—Pain—Bleomycin—skin cancer	0.000455	0.00176	CcSEcCtD
Montelukast—Conjunctivitis—Docetaxel—skin cancer	0.000455	0.00176	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000453	0.00175	CcSEcCtD
Montelukast—Anaphylactic shock—Temozolomide—skin cancer	0.000449	0.00174	CcSEcCtD
Montelukast—Oedema—Temozolomide—skin cancer	0.000449	0.00174	CcSEcCtD
Montelukast—Infection—Temozolomide—skin cancer	0.000446	0.00173	CcSEcCtD
Montelukast—Nausea—Imiquimod—skin cancer	0.000445	0.00172	CcSEcCtD
Montelukast—Hepatobiliary disease—Docetaxel—skin cancer	0.000443	0.00172	CcSEcCtD
Montelukast—Epistaxis—Docetaxel—skin cancer	0.000442	0.00171	CcSEcCtD
Montelukast—Nervous system disorder—Temozolomide—skin cancer	0.000441	0.00171	CcSEcCtD
Montelukast—Thrombocytopenia—Temozolomide—skin cancer	0.00044	0.0017	CcSEcCtD
Montelukast—Convulsion—Fluorouracil—skin cancer	0.000439	0.0017	CcSEcCtD
Montelukast—PTGS1—endothelium—skin cancer	0.000439	0.0552	CbGeAlD
Montelukast—Skin disorder—Temozolomide—skin cancer	0.000436	0.00169	CcSEcCtD
Montelukast—Myalgia—Fluorouracil—skin cancer	0.000432	0.00167	CcSEcCtD
Montelukast—Fatigue—Dactinomycin—skin cancer	0.000428	0.00166	CcSEcCtD
Montelukast—Pain—Dactinomycin—skin cancer	0.000425	0.00164	CcSEcCtD
Montelukast—Urticaria—Bleomycin—skin cancer	0.000423	0.00164	CcSEcCtD
Montelukast—Rhinitis—Docetaxel—skin cancer	0.000422	0.00163	CcSEcCtD
Montelukast—Body temperature increased—Bleomycin—skin cancer	0.000421	0.00163	CcSEcCtD
Montelukast—Hepatitis—Docetaxel—skin cancer	0.000421	0.00163	CcSEcCtD
Montelukast—Hypoaesthesia—Docetaxel—skin cancer	0.000418	0.00162	CcSEcCtD
Montelukast—Pharyngitis—Docetaxel—skin cancer	0.000417	0.00162	CcSEcCtD
Montelukast—Urinary tract disorder—Docetaxel—skin cancer	0.000415	0.00161	CcSEcCtD
Montelukast—Oedema—Fluorouracil—skin cancer	0.000414	0.0016	CcSEcCtD
Montelukast—Anaphylactic shock—Fluorouracil—skin cancer	0.000414	0.0016	CcSEcCtD
Montelukast—Connective tissue disorder—Docetaxel—skin cancer	0.000413	0.0016	CcSEcCtD
Montelukast—Urethral disorder—Docetaxel—skin cancer	0.000412	0.0016	CcSEcCtD
Montelukast—Infection—Fluorouracil—skin cancer	0.000411	0.00159	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000409	0.00158	CcSEcCtD
Montelukast—Insomnia—Temozolomide—skin cancer	0.000406	0.00157	CcSEcCtD
Montelukast—Gastrointestinal pain—Dactinomycin—skin cancer	0.000406	0.00157	CcSEcCtD
Montelukast—Nervous system disorder—Fluorouracil—skin cancer	0.000406	0.00157	CcSEcCtD
Montelukast—Thrombocytopenia—Fluorouracil—skin cancer	0.000405	0.00157	CcSEcCtD
Montelukast—PTGS1—blood vessel—skin cancer	0.000405	0.0509	CbGeAlD
Montelukast—Paraesthesia—Temozolomide—skin cancer	0.000403	0.00156	CcSEcCtD
Montelukast—Somnolence—Temozolomide—skin cancer	0.000399	0.00155	CcSEcCtD
Montelukast—Erythema multiforme—Docetaxel—skin cancer	0.000398	0.00154	CcSEcCtD
Montelukast—Dyspepsia—Temozolomide—skin cancer	0.000395	0.00153	CcSEcCtD
Montelukast—Abdominal pain—Dactinomycin—skin cancer	0.000393	0.00152	CcSEcCtD
Montelukast—Body temperature increased—Dactinomycin—skin cancer	0.000393	0.00152	CcSEcCtD
Montelukast—Hypersensitivity—Bleomycin—skin cancer	0.000392	0.00152	CcSEcCtD
Montelukast—Cardiac disorder—Docetaxel—skin cancer	0.00039	0.00151	CcSEcCtD
Montelukast—Gastrointestinal disorder—Temozolomide—skin cancer	0.000388	0.0015	CcSEcCtD
Montelukast—Fatigue—Temozolomide—skin cancer	0.000387	0.0015	CcSEcCtD
Montelukast—Pain—Temozolomide—skin cancer	0.000384	0.00149	CcSEcCtD
Montelukast—Asthenia—Bleomycin—skin cancer	0.000382	0.00148	CcSEcCtD
Montelukast—Immune system disorder—Docetaxel—skin cancer	0.00038	0.00147	CcSEcCtD
Montelukast—Mediastinal disorder—Docetaxel—skin cancer	0.000379	0.00147	CcSEcCtD
Montelukast—ALOX5—lymphoid tissue—skin cancer	0.000378	0.0475	CbGeAlD
Montelukast—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000377	0.00146	CcSEcCtD
Montelukast—Pruritus—Bleomycin—skin cancer	0.000377	0.00146	CcSEcCtD
Montelukast—Insomnia—Fluorouracil—skin cancer	0.000374	0.00145	CcSEcCtD
Montelukast—Paraesthesia—Fluorouracil—skin cancer	0.000372	0.00144	CcSEcCtD
Montelukast—Mental disorder—Docetaxel—skin cancer	0.000368	0.00143	CcSEcCtD
Montelukast—Somnolence—Fluorouracil—skin cancer	0.000368	0.00142	CcSEcCtD
Montelukast—Gastrointestinal pain—Temozolomide—skin cancer	0.000367	0.00142	CcSEcCtD
Montelukast—Hypersensitivity—Dactinomycin—skin cancer	0.000366	0.00142	CcSEcCtD
Montelukast—ALOX5—female reproductive system—skin cancer	0.000365	0.0458	CbGeAlD
Montelukast—Dyspepsia—Fluorouracil—skin cancer	0.000364	0.00141	CcSEcCtD
Montelukast—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000357	0.00138	CcSEcCtD
Montelukast—Urticaria—Temozolomide—skin cancer	0.000357	0.00138	CcSEcCtD
Montelukast—Asthenia—Dactinomycin—skin cancer	0.000356	0.00138	CcSEcCtD
Montelukast—Abdominal pain—Temozolomide—skin cancer	0.000355	0.00138	CcSEcCtD
Montelukast—Body temperature increased—Temozolomide—skin cancer	0.000355	0.00138	CcSEcCtD
Montelukast—Pain—Fluorouracil—skin cancer	0.000354	0.00137	CcSEcCtD
Montelukast—CYSLTR1—lymph node—skin cancer	0.000353	0.0443	CbGeAlD
Montelukast—Muscle spasms—Docetaxel—skin cancer	0.000352	0.00136	CcSEcCtD
Montelukast—Diarrhoea—Dactinomycin—skin cancer	0.00034	0.00132	CcSEcCtD
Montelukast—Vomiting—Bleomycin—skin cancer	0.000339	0.00131	CcSEcCtD
Montelukast—Rash—Bleomycin—skin cancer	0.000336	0.0013	CcSEcCtD
Montelukast—Dermatitis—Bleomycin—skin cancer	0.000336	0.0013	CcSEcCtD
Montelukast—Hypersensitivity—Temozolomide—skin cancer	0.000331	0.00128	CcSEcCtD
Montelukast—Urticaria—Fluorouracil—skin cancer	0.000329	0.00127	CcSEcCtD
Montelukast—Body temperature increased—Fluorouracil—skin cancer	0.000327	0.00127	CcSEcCtD
Montelukast—Palpitations—Docetaxel—skin cancer	0.000324	0.00125	CcSEcCtD
Montelukast—Asthenia—Temozolomide—skin cancer	0.000322	0.00125	CcSEcCtD
Montelukast—Cough—Docetaxel—skin cancer	0.000319	0.00124	CcSEcCtD
Montelukast—Pruritus—Temozolomide—skin cancer	0.000318	0.00123	CcSEcCtD
Montelukast—Convulsion—Docetaxel—skin cancer	0.000317	0.00123	CcSEcCtD
Montelukast—Nausea—Bleomycin—skin cancer	0.000316	0.00122	CcSEcCtD
Montelukast—Vomiting—Dactinomycin—skin cancer	0.000316	0.00122	CcSEcCtD
Montelukast—Rash—Dactinomycin—skin cancer	0.000313	0.00121	CcSEcCtD
Montelukast—Myalgia—Docetaxel—skin cancer	0.000312	0.00121	CcSEcCtD
Montelukast—Arthralgia—Docetaxel—skin cancer	0.000312	0.00121	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00031	0.0012	CcSEcCtD
Montelukast—Diarrhoea—Temozolomide—skin cancer	0.000307	0.00119	CcSEcCtD
Montelukast—Hypersensitivity—Fluorouracil—skin cancer	0.000305	0.00118	CcSEcCtD
Montelukast—ALOX5—head—skin cancer	0.000305	0.0383	CbGeAlD
Montelukast—Oedema—Docetaxel—skin cancer	0.000299	0.00116	CcSEcCtD
Montelukast—Anaphylactic shock—Docetaxel—skin cancer	0.000299	0.00116	CcSEcCtD
Montelukast—Dizziness—Temozolomide—skin cancer	0.000297	0.00115	CcSEcCtD
Montelukast—Infection—Docetaxel—skin cancer	0.000297	0.00115	CcSEcCtD
Montelukast—Nausea—Dactinomycin—skin cancer	0.000295	0.00114	CcSEcCtD
Montelukast—Nervous system disorder—Docetaxel—skin cancer	0.000293	0.00113	CcSEcCtD
Montelukast—Pruritus—Fluorouracil—skin cancer	0.000293	0.00113	CcSEcCtD
Montelukast—PTGS1—nipple—skin cancer	0.000293	0.0368	CbGeAlD
Montelukast—Thrombocytopenia—Docetaxel—skin cancer	0.000293	0.00113	CcSEcCtD
Montelukast—Skin disorder—Docetaxel—skin cancer	0.00029	0.00112	CcSEcCtD
Montelukast—Vomiting—Temozolomide—skin cancer	0.000286	0.00111	CcSEcCtD
Montelukast—Rash—Temozolomide—skin cancer	0.000283	0.0011	CcSEcCtD
Montelukast—Diarrhoea—Fluorouracil—skin cancer	0.000283	0.0011	CcSEcCtD
Montelukast—Dermatitis—Temozolomide—skin cancer	0.000283	0.0011	CcSEcCtD
Montelukast—Headache—Temozolomide—skin cancer	0.000281	0.00109	CcSEcCtD
Montelukast—SLCO2B1—female reproductive system—skin cancer	0.000281	0.0353	CbGeAlD
Montelukast—Dizziness—Fluorouracil—skin cancer	0.000274	0.00106	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000272	0.00105	CcSEcCtD
Montelukast—Insomnia—Docetaxel—skin cancer	0.00027	0.00105	CcSEcCtD
Montelukast—Paraesthesia—Docetaxel—skin cancer	0.000268	0.00104	CcSEcCtD
Montelukast—Nausea—Temozolomide—skin cancer	0.000267	0.00103	CcSEcCtD
Montelukast—Somnolence—Docetaxel—skin cancer	0.000266	0.00103	CcSEcCtD
Montelukast—Vomiting—Fluorouracil—skin cancer	0.000263	0.00102	CcSEcCtD
Montelukast—Dyspepsia—Docetaxel—skin cancer	0.000263	0.00102	CcSEcCtD
Montelukast—Rash—Fluorouracil—skin cancer	0.000261	0.00101	CcSEcCtD
Montelukast—Dermatitis—Fluorouracil—skin cancer	0.000261	0.00101	CcSEcCtD
Montelukast—Headache—Fluorouracil—skin cancer	0.000259	0.001	CcSEcCtD
Montelukast—Gastrointestinal disorder—Docetaxel—skin cancer	0.000258	0.000999	CcSEcCtD
Montelukast—Fatigue—Docetaxel—skin cancer	0.000258	0.000997	CcSEcCtD
Montelukast—Pain—Docetaxel—skin cancer	0.000256	0.000989	CcSEcCtD
Montelukast—Nausea—Fluorouracil—skin cancer	0.000246	0.000952	CcSEcCtD
Montelukast—Gastrointestinal pain—Docetaxel—skin cancer	0.000244	0.000946	CcSEcCtD
Montelukast—Body temperature increased—Docetaxel—skin cancer	0.000236	0.000915	CcSEcCtD
Montelukast—Abdominal pain—Docetaxel—skin cancer	0.000236	0.000915	CcSEcCtD
Montelukast—SLCO2B1—head—skin cancer	0.000235	0.0295	CbGeAlD
Montelukast—Hypersensitivity—Docetaxel—skin cancer	0.00022	0.000852	CcSEcCtD
Montelukast—Asthenia—Docetaxel—skin cancer	0.000214	0.00083	CcSEcCtD
Montelukast—ALOX5—lymph node—skin cancer	0.000213	0.0268	CbGeAlD
Montelukast—Pruritus—Docetaxel—skin cancer	0.000211	0.000818	CcSEcCtD
Montelukast—PTGS1—connective tissue—skin cancer	0.000208	0.0261	CbGeAlD
Montelukast—Diarrhoea—Docetaxel—skin cancer	0.000204	0.000792	CcSEcCtD
Montelukast—Dizziness—Docetaxel—skin cancer	0.000198	0.000765	CcSEcCtD
Montelukast—PTGS1—epithelium—skin cancer	0.000197	0.0248	CbGeAlD
Montelukast—Vomiting—Docetaxel—skin cancer	0.00019	0.000736	CcSEcCtD
Montelukast—Rash—Docetaxel—skin cancer	0.000188	0.000729	CcSEcCtD
Montelukast—Dermatitis—Docetaxel—skin cancer	0.000188	0.000729	CcSEcCtD
Montelukast—PTGS1—skin of body—skin cancer	0.000188	0.0236	CbGeAlD
Montelukast—Headache—Docetaxel—skin cancer	0.000187	0.000725	CcSEcCtD
Montelukast—CYP2C8—female reproductive system—skin cancer	0.000181	0.0227	CbGeAlD
Montelukast—Nausea—Docetaxel—skin cancer	0.000177	0.000687	CcSEcCtD
Montelukast—PTGS1—mammalian vulva—skin cancer	0.000171	0.0215	CbGeAlD
Montelukast—SLCO2B1—lymph node—skin cancer	0.000164	0.0206	CbGeAlD
Montelukast—CYP2C9—female reproductive system—skin cancer	0.00016	0.0201	CbGeAlD
Montelukast—PTGS1—female reproductive system—skin cancer	0.000146	0.0184	CbGeAlD
Montelukast—PTGS1—head—skin cancer	0.000122	0.0154	CbGeAlD
Montelukast—CYP3A4—female reproductive system—skin cancer	0.000122	0.0154	CbGeAlD
Montelukast—PTGS1—lymph node—skin cancer	8.57e-05	0.0108	CbGeAlD
